ABUS vs DRI
Arbutus Biopharma Corp (ABUS) versus Darden Restaurants Inc (DRI) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Darden Restaurants Inc (DRI) is a restaurants company listed on NYSE.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported DRI revenue for 2025-05-25 was $12.08B. Net income was $1.05B. Revenue was up 6.0% from 2024-05-26 to 2025-05-25. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
Not investment advice. Open the ABUS and DRI stock pages for the full models.
Not investment advice.